SCHAUMBURG, IL – Nearly 1400 Staples stores will soon carry the innovative Century® Copper pen by A.T. Cross. Part of the Cross signature Classic Century® collection, the Century Copper pen is made from CuVerro® bactericidal touch surface which kills 99.9% of bacteria* within two hours of contact, including MRSA. An EPA-registered copper alloy, the properties of CuVerro have been proven effective 24/7, never washing out or wearing away- making the Century Copper pen an innovative writing tool continuously killing bacteria in the workplace, at home, and on-the-go.
“Winter and holidays are typically fraught with increased sickness and hygiene concerns” said Kon John, Director CuVerro Business and Market Development. “With the current heightened fear of bacterial contamination, the Century Copper pen with CuVerro® is a timely innovation. We are thrilled Staples is carrying this breakthrough pen.”
Available the week of November 10th, Staples will feature the Century Copper pen in the Specialty Pen section of their writing aisle, an area that features pens that are unique in form and function. The distinctive Century Copper ballpoint pen will be priced at $29.99.
The Century Copper pen boasts a sleek iconic design with the stunning CuVerro copper alloy surface. "This pen furthers our reputation for quality craftsmanship and moves our brand ahead with a writing tool that truly will make a difference in today's health conscious environment" said Chad Mellen, CEO of A.T. Cross Co. "I've used my Cross Century pen made with CuVerro for over two years now and I always feel comfortable letting its many admirers 'borrow it' to see and feel what a great product it is. This is a great addition to our collection of writing instruments Staples will now carry nationwide."
*Laboratory testing shows that, when cleaned regularly, CuVerro surfaces kill greater than 99.9% of the following bacteria within 2 hours of exposure: Methicillin-Resistant Staphylococcus aureus, Staphylococcus aureus, Enterobacter aerogenes, Pseudomonas aeruginosa, E. coli O157:H7, and Vancomycin-Resistant Enterococcus faecalis (VRE).The use of CuVerro® antimicrobial copper products is a supplement to and not a substitute for standard infection control practices; users must continue to follow all current infection control practices, including those practices related to cleaning and disinfection of environmental surfaces. This surface has been shown to reduce microbial contamination, but it does not necessarily prevent cross contamination.
CuVerro® is manufactured by GBC Metals, LLC, doing business as Olin Brass, a wholly owned subsidiary of Global Brass and Copper, Inc. which is a subsidiary of Global Brass and Copper Holdings, Inc., the leading manufacturer and distributor of copper, copper-alloy and bactericidal copper sheet, strip, plate, foil, rod, ingot and fabricated components in North America and one of the largest in the world. GBC Metals engages in the melting, casting, rolling, drawing, extruding and stamping of specialized copper and copper alloys finished products from scrap, cathode and other refined metals. For more information about CuVerro, email Kon John, Director CuVerro Market and Business Development, at Kon.John@olinbrass.com, visit www.cuverro.com or call 1-877-311-2883. (OB-0023-1411)
About A.T. Cross Company
A.T. CROSS COMPANY, the world renowned manufacturer and marketer of fine writing instruments, has achieved worldwide recognition as a brand since the firm’s inception in 1846. The CROSS name has been synonymous with quality writing instruments, and its collection has expanded to include other fine accessories for where and how you work including timepieces, leather, eyewear, and journals. CROSS is headquartered in Lincoln, Rhode Island, and its products are sold in 89 countries worldwide through select retailers and distribution partners. All CROSS writing instruments are backed by a lifetime mechanical guarantee. CROSS selections bring the collective skills of 168 years of innovation and craftsmanship to a whole new generation of products. For further information about CROSS, please visit www.cross.com.